Postoperative glioblastoma management: from relapse mechanisms and clinical interventions to emerging drug delivery strategies.
The clinical and biological basis of postoperative GBM recurrence is summarized, and integrated delivery systems combining local retention, systemic targeting, programmable release, and microenvironmental regulation to improve postoperative GBM therapy are highlighted.